Insights into liaison between antiepileptic drugs and bone
Authors:
- Krishna K. PillaiKPKrishna K. Pillai
- Divya VohoraDVDivya Vohora
- 1 April 2009
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 14 (7-8) , 428-435
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Aromatase expression in osteoarthritic and osteoporotic boneArthritis & Rheumatism, 2008
- Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutationsBest Practice & Research Clinical Rheumatology, 2008
- Levetiracetam, Phenytoin, and Valproate Act Differently on Rat Bone Mass, Structure, and MetabolismEpilepsia, 2007
- The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trialThe Lancet, 2007
- Estrogen deficiency and bone loss: an inflammatory taleJournal of Clinical Investigation, 2006
- Current insights into the role of transforming growth factor-β in bone resorptionMolecular and Cellular Endocrinology, 2005
- Estrogen Supplementation for Bone Dematuration in Young Epileptic Man Treated with Anticonvulsant Therapy; A Case Report.Endocrine Journal, 1999
- Effects of anti-epileptic drug therapy on bone mineral density in ambulatory epileptic childrenBrain and Development, 1994
- Inhibition by phenytoin ofin vitrosecretion of calcitonin from rat thyroid glands and cultured rat C cellsJournal of Bone and Mineral Research, 1988
- Valproic acid-induced neural tube defects: Reduction by folinic acid in the mouseLife Sciences, 1987